Source-grounded facts extracted from CareView Communications Inc's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
CareView Communications Inc amended credit facility of No change to principal amount stated with PDL Investment Holdings, LLC at No change to interest rate stated maturing Maturity Date extended to June 30, 2026.
“the parties agreed to amend the Credit Agreement to (i) provide that the Maturity Date shall be extended to June 30, 2026.”
CareView Communications Inc amended Fourteenth Amendment to CA with PDL Investment Holdings, LLC, Steven G. Johnson, Dr. James R. Higgins (effective 2026-03-30).
“As of March 30, 2026, the Company, the Borrower, the Lender, Steven G. Johnson, President and Chief Executive Officer of the Company, and Dr. James R. Higgins, a director of the Company, entered into a Fourteenth Amendment to CA (the “Fourteenth Amendment to Credit Agreement”), pursuant to which the parties agreed to amend the Credit Agreement to (i) provide that the Maturity Date shall be extended to June 30, 2026.”
CareView Communications Inc amended Thirteenth Amendment to Credit Agreement with PDL Investment Holdings, LLC (effective 2025-12-31).
“As of December 31, 2025, the Company, the Borrower, the Lender, Steven G. Johnson, President and Chief Executive Officer of the Company, and Dr. James R. Higgins, a director of the Company, entered into a Thirteenth Amendment to CA (the “Thirteenth Amendment to Credit Agreement”), pursuant to which the parties agreed to amend the Credit Agreement to (i) provide that the Maturity Date shall be extended to March 31, 2026.”
CareView Communications Inc amended credit facility with PDL Investment Holdings, LLC maturing March 31, 2026.
“pursuant to which the parties agreed to amend the Credit Agreement to (i) provide that the Maturity Date shall be extended to March 31, 2026.”
CareView Communications Inc amended credit facility with PDL Investment Holdings, LLC maturing December 31, 2025.
“pursuant to which the parties agreed to amend the Credit Agreement to (i) provide that the Maturity Date shall be extended to December 31, 2025.”
CareView Communications Inc amended credit facility with PDL Investment Holdings, LLC maturing June 30, 2025.
“On March 21, 2025 (the "Effective Date"), the Company, the Borrower, the Lender, Steven G. Johnson, President and Chief Executive Officer of the Company, and Dr. James R. Higgins, a director of the Company, entered into a Tenth Amendment to Credit Agreement (the "Tenth Credit Agreement Amendment"), pursuant to which the parties agreed to amend the Credit Agreement to (i) provide that the Maturity Date shall be extended to June 30, 2025.”
CareView Communications Inc amended credit facility with PDL Investment Holdings, LLC maturing December 31, 2024.
“On May 31, 2023 (the “Effective Date”), the Company, the Borrower, the Lender, Steven G. Johnson, President and Chief Executive Officer of the Company, and Dr. James R. Higgins, a director of the Company, entered into a Seventh Amendment to Credit Agreement (the “Seventh Credit Agreement Amendment”), pursuant to which the parties agreed to amend the Credit Agreement to, among other things, (i) provide that, after the Effective Date, all accrued but unpaid interest (including interest accrued but unpaid prior to the Effective Date and excluding interest payable on the Maturity Date, in connection with any prepayment, or in the event of an Event of Default, which interest will be payable in cash) accruing on Tranche One Loans and Tranche Three Loans will be paid-in-kind on each Interest Payment Date by being added to the aggregate principal balance of the respective loans in arrears on each Interest Payment Date; (ii) require certain mandatory prepayments of the loans by the Company, inc”
CareView Communications Inc amended Seventh Amendment to Credit Agreement with PDL Investment Holdings, LLC (as assignee of PDL BioPharma, Inc.), in its capacity as administrative agent and lender (effective 2023-05-31).
“On May 31, 2023 (the “Effective Date”), the Company, the Borrower, the Lender, Steven G. Johnson, President and Chief Executive Officer of the Company, and Dr. James R. Higgins, a director of the Company, entered into a Seventh Amendment to Credit Agreement (the “Seventh Credit Agreement Amendment”),”
CareView Communications Inc amended Thirtieth Amendment to Modification Agreement with PDL Investment Holdings, LLC valued at Amendment to credit agreement modification terms (effective 2023-05-02).
“Thirtieth Amendment to Modification Agreement Modification Agreement to Credit Agreement As previously reported by CareView Communications, Inc. (the "Company") in our Current Report on Form 8-K filed with the Securities and Exchange Commission (the "SEC") on February 5, 2018, the Company, CareView Communications, Inc., a Texas corporation and a wholly owned subsidiary of the Company (the "Borrower"), CareView Operations, L.L.C., a Texas limited liability company and a wholly owned subsidiary of the Borrower (the "Subsidiary Guarantor"), and PDL Investment Holdings, LLC (as assignee of PDL BioPharma, Inc.), in its capacity as administrative agent and lender (the "Lender") under the Credit Agreement (the "Credit Agreement") dated as of June 26, 2015, as amended, by and among the Company, the Borrower and the Lender, entered into a Modification Agreement on February 2, 2018, effective as of December 28, 2017 (the "Modification Agreement"), with respect to the Credit Agreement in order to”
CareView Communications Inc entered into Replacement Note Conversion Agreement with Investors valued at Conversion of $26,200,000 of Replacement Notes into 262,000,000 shares of common stock at $0.10 per (effective 2023-03-30).
“On March 30, 2023, noteholders owning an aggregate of $26,200,000 Replacement Notes, entered into a Replacement Note Conversion Agreement, wherein the Replacement Notes were converted into shares of the Company’s common stock at a conversion price of $0.10 per share, resulting in the issuance of an aggregate of 262,000,000 shares (the “Conversion Shares”).”
CareView Communications Inc entered into Replacement Note Conversion Agreement with certain noteholders valued at Conversion of $26,200,000 Replacement Notes into 262,000,000 shares of common stock at $0.10 per sha (effective 2023-03-30).
“On March 30, 2023, noteholders owning an aggregate of $26,200,000 Replacement Notes, entered into a Replacement Note Conversion Agreement, wherein the Replacement Notes were converted into shares of the Company’s common stock at a conversion price of $0.10 per share, resulting in the issuance of an aggregate of 262,000,000 shares (the “Conversion Shares”).”
CareView Communications Inc amended Twenty-Sixth Amendment to Modification Agreement.
“Item 1.01 Entry into a Material Definitive Agreement. Twenty-Sixth Amendment to Modification Agreement Modification Agreement to Credit Agreement”
CareView Communications Inc incurred convertible notes of $44,900,000 at no interest maturing December 31, 2023.
“The Cancellation Agreement provided for the cancellation of all outstanding Notes (with a total aggregate outstanding amount of approximately $88,300,000) and Warrants (for the purchase of an aggregate of approximately 15,400,000 shares of common stock) issued pursuant to the Purchase Agreement in exchange for the issuance of replacement senior secured convertible promissory notes (the “Replacement Notes”) with an aggregate principal amount of $44,900,000. The Replacement Notes have a maturity date of December 31, 2023. No interest will accrue on the Replacement Notes.”
CareView Communications Inc entered into Consent and Agreement to Cancel and Exchange Existing Notes and Issue Replacement Notes and Cancel Warrants.
“This Senior Secured Convertible Note (this “ Note ”) is being issued pursuant to that certain Consent and Agreement to Cancel and Exchange Existing Notes and Issue Replacement Notes and Cancel Warrants (the “ Agreement ”)”
CareView Communications Inc entered into Purchase Agreement with certain purchasers valued at $250,000 (effective 2022-11-14).
“On November 14, 2022, CareView Communications, Inc. (“CareView” or the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain purchasers (the “Investors”), which provided for the sale of $250,000 of common stock of the Company, par value $0.001 per share (the “Shares”), at a cash purchase price of $0.10 per share.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.